Table 3 Effect of CurNPs and ZnONPs administration on serum lipid profile TC, TG, HDL-c and LDL levels of STZ-induced diabetic and control rats.

From: Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes

Groups

TC (mg/dl)

HDL-c (mg/dl)

TG (mg/dl)

LDL-c (mg/dl)

Control

80.6 ± 0.68e

59.80 ± 0.58a

92.60 ± 0.93 h

2.28 ± 0.67f.

HFD/STZ

532.80 ± 1.66a

24.80 ± 0.66d

391.00 ± 0.71a

229.80 ± 1.16a

HFD/STZ-Cur

161.00 ± 0.71b

41.00 ± 0.71b,c

201.00 ± 0.71c

79.80 ± 0.91b

HFD/STZ-CurNPs-10

70.00 ± 0.71f.

40.00 ± 0.71c

122.00 ± 0.71f.

5.60 ± 0.49e

HFD/STZ-CurNPs-50

74.80 ± 0.86f.

41.40 ± 0.93b,c

131.00 ± 0.71e

7.20 ± 0.42d

HFD/STZ- ZnSO4

109.20 ± 2.35c

43.60 ± 1.03b

217.80 ± 0.86b

22.04 ± 2.54c

HFD/STZ-ZnONPs-10

90.60 ± 0.93d

42.00 ± 0.71b

110.00 ± 0.71 g

26.60 ± 0.76c

HFD/STZ-ZnONPs-50

70.00 ± 0.71f.

42.60 ± 0.93b

119.80 ± 0.86 g

3.44 ± 1.09f.

HFD/STZ-MT

83.00 ± 0.71e

45.00 ± 0.71b

144.00 ± 0.71d

9.20 ± 0.97d

  1. Values are expressed as mean ± SEM (n = 7), means for the same parameter with different letters in each column are significantly different (Tukey, p < 0.01).